Citius Pharma Files 8-K on Security Holder Rights & Bylaws
Ticker: CTXR · Form: 8-K · Filed: Jun 9, 2025 · CIK: 1506251
Sentiment: neutral
Topics: corporate-governance, filing, bylaws
Related Tickers: CTRS
TL;DR
CTRS filed an 8-K covering changes to security holder rights and bylaws. Keep an eye on governance shifts.
AI Summary
Citius Pharmaceuticals, Inc. filed an 8-K on June 9, 2025, reporting on several items including material modifications to security holder rights, amendments to its articles of incorporation or bylaws, and submission of matters to a vote of security holders. The filing also includes financial statements and exhibits.
Why It Matters
This filing indicates potential changes in the company's governance or security holder agreements, which could impact investor rights and the company's operational structure.
Risk Assessment
Risk Level: medium — Filings related to modifications of security holder rights and amendments to bylaws can signal significant corporate governance changes that may affect the company's future direction and investor relations.
Key Players & Entities
- Citius Pharmaceuticals, Inc. (company) — Registrant
- June 9, 2025 (date) — Date of Report
- Nevada (jurisdiction) — State of Incorporation
- 001-38174 (identifier) — Commission File Number
- 27-3425913 (identifier) — IRS Employer Identification Number
FAQ
What specific material modifications were made to the rights of Citius Pharmaceuticals, Inc. security holders?
The filing indicates 'Material Modifications to Rights of Security Holders' as an item information, but the specific details of these modifications are not provided in the provided text excerpt.
Were there any amendments to Citius Pharmaceuticals, Inc.'s articles of incorporation or bylaws?
Yes, the filing lists 'Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year' as an item information, suggesting such amendments were made or reported.
Were any matters submitted to a vote of Citius Pharmaceuticals, Inc. security holders?
The filing includes 'Submission of Matters to a Vote of Security Holders' as an item information, indicating that matters were indeed put to a vote.
What is the fiscal year end for Citius Pharmaceuticals, Inc.?
The fiscal year end for Citius Pharmaceuticals, Inc. is September 30 (0930).
What is the SIC code for Citius Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code for Citius Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 9, 2025 regarding Citius Pharmaceuticals, Inc. (CTXR).